These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 38584226)

  • 1. Analysis of the differential expression of serum miR-21-5p, miR-135-5p, and miR-155-5p by Bifidobacterium triplex viable capsules during the perioperative stage of colorectal cancer.
    Zhang J; Guo J; He R; Li J; Du B; Zhang Y; He R; Cheng H
    Int J Colorectal Dis; 2024 Apr; 39(1):48. PubMed ID: 38584226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of serum miR-30a-5p as a diagnostic and prognostic biomarker in colorectal cancer.
    Sun Y; Yang B; Lin M; Yu H; Chen H; Zhang Z
    Cancer Biomark; 2019; 24(3):299-305. PubMed ID: 30829615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Downregulation of miR-193a-5p correlates with lymph node metastasis and poor prognosis in colorectal cancer.
    Zhang P; Ji DB; Han HB; Shi YF; Du CZ; Gu J
    World J Gastroenterol; 2014 Sep; 20(34):12241-8. PubMed ID: 25232258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Downregulation of serum exosomal miR-150-5p is associated with poor prognosis in patients with colorectal cancer.
    Zou SL; Chen YL; Ge ZZ; Qu YY; Cao Y; Kang ZX
    Cancer Biomark; 2019; 26(1):69-77. PubMed ID: 31306108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma microRNA-1207-5p as a Potential Biomarker for Diagnosis and Prognosis of Colorectal Cancer.
    Wang X; Li L; Xiao W; Xu Q
    Clin Lab; 2020 Sep; 66(9):. PubMed ID: 32902212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-675-5p Overexpression Is an Independent Prognostic Molecular Biomarker of Short-Term Relapse and Poor Overall Survival in Colorectal Cancer.
    Christodoulou S; Sotiropoulou CD; Vassiliu P; Danias N; Arkadopoulos N; Sideris DC
    Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer-associated fibroblasts drive colorectal cancer cell progression through exosomal miR-20a-5p-mediated targeting of PTEN and stimulating interleukin-6 production.
    Ghofrani-Shahpar M; Pakravan K; Razmara E; Amooie F; Mahmoudian M; Heshmati M; Babashah S
    BMC Cancer; 2024 Apr; 24(1):400. PubMed ID: 38561726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression levels of miR-143-3p and -424-5p in colorectal cancer and their clinical significance.
    Sahami-Fard MH; Kheirandish S; Sheikhha MH
    Cancer Biomark; 2019; 24(3):291-297. PubMed ID: 30883340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A panel of serum exosomal microRNAs as predictive markers for chemoresistance in advanced colorectal cancer.
    Jin G; Liu Y; Zhang J; Bian Z; Yao S; Fei B; Zhou L; Yin Y; Huang Z
    Cancer Chemother Pharmacol; 2019 Aug; 84(2):315-325. PubMed ID: 31089750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression level of miR-383-5p in colorectal cancer patients following neoadjuvant chemotherapy and its clinical significance in the prognosis.
    Sun X; Wang X; Dong G; Zhao Z; Song J
    Minerva Med; 2023 Aug; 114(4):485-490. PubMed ID: 32700862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A panel of seven-miRNA signature in plasma as potential biomarker for colorectal cancer diagnosis.
    Zhang H; Zhu M; Shan X; Zhou X; Wang T; Zhang J; Tao J; Cheng W; Chen G; Li J; Liu P; Wang Q; Zhu W
    Gene; 2019 Mar; 687():246-254. PubMed ID: 30458288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of miR-195-5p as a novel prognostic biomarker for colorectal cancer.
    Bayat A; Raad M; Sharafshah A; Ahmadvand M; Aminian H
    Mol Biol Rep; 2022 Jul; 49(7):6453-6457. PubMed ID: 35587844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-6869-5p acts as a tumor suppressor via targeting TLR4/NF-κB signaling pathway in colorectal cancer.
    Yan S; Liu G; Jin C; Wang Z; Duan Q; Xu J; Xu D
    J Cell Physiol; 2018 Sep; 233(9):6660-6668. PubMed ID: 29206292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miRNA-99b-5p suppresses liver metastasis of colorectal cancer by down-regulating mTOR.
    Li W; Chang J; Wang S; Liu X; Peng J; Huang D; Sun M; Chen Z; Zhang W; Guo W; Li J
    Oncotarget; 2015 Sep; 6(27):24448-62. PubMed ID: 26259252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiR-340-5p is a potential prognostic indicator of colorectal cancer and modulates ANXA3.
    Yang L; Men WL; Yan KM; Tie J; Nie YZ; Xiao HJ
    Eur Rev Med Pharmacol Sci; 2018 Aug; 22(15):4837-4845. PubMed ID: 30070320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and biological significance of miR-378a-3p and miR-378a-5p in colorectal cancer.
    Li H; Dai S; Zhen T; Shi H; Zhang F; Yang Y; Kang L; Liang Y; Han A
    Eur J Cancer; 2014 Apr; 50(6):1207-21. PubMed ID: 24412052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating Plasma Levels of miR-20b, miR-29b and miR-155 as Predictors of Bevacizumab Efficacy in Patients with Metastatic Colorectal Cancer.
    Ulivi P; Canale M; Passardi A; Marisi G; Valgiusti M; Frassineti GL; Calistri D; Amadori D; Scarpi E
    Int J Mol Sci; 2018 Jan; 19(1):. PubMed ID: 29361687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiR-96-5p influences cellular growth and is associated with poor survival in colorectal cancer patients.
    Ress AL; Stiegelbauer V; Winter E; Schwarzenbacher D; Kiesslich T; Lax S; Jahn S; Deutsch A; Bauernhofer T; Ling H; Samonigg H; Gerger A; Hoefler G; Pichler M
    Mol Carcinog; 2015 Nov; 54(11):1442-50. PubMed ID: 25256312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-140-5p inhibits the progression of colorectal cancer by targeting VEGFA.
    Zhang W; Zou C; Pan L; Xu Y; Qi W; Ma G; Hou Y; Jiang P
    Cell Physiol Biochem; 2015; 37(3):1123-33. PubMed ID: 26402430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-378a-5p inhibits the proliferation of colorectal cancer cells by downregulating CDK1.
    Li K; Zhang J; Zhang M; Wu Y; Lu X; Zhu Y
    World J Surg Oncol; 2021 Feb; 19(1):54. PubMed ID: 33608020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.